SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1
Journal Article
·
· ACS Medicinal Chemistry Letters
more »
- Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States
- Department of Medicine, Division of Allergy and Infectious Diseases, and the Center for Emerging and Re-emerging Infectious Diseases (CERID), University of Washington, Seattle, Washington 98109, United States
- Department of Chemistry, University of Washington, Seattle, Washington 98195, United States
- Center for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, Washington 98109, United States
- Portland VA Medical Center, Portland, Oregon 97239, United States
- AbbVie, N. Chicago, Illinois 60064, United States
- PATH, San Francisco, California 94102, United States
- Department of Pharmaceutics, University of Washington, Seattle, Washington 98195, United States
- Center for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, Washington 98109, United States, Department of Global Health, University of Washington, Seattle, Washington 98195, United States
- Department of Medicine, Division of Allergy and Infectious Diseases, and the Center for Emerging and Re-emerging Infectious Diseases (CERID), University of Washington, Seattle, Washington 98109, United States, Department of Global Health, University of Washington, Seattle, Washington 98195, United States
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1227228
- Journal Information:
- ACS Medicinal Chemistry Letters, Journal Name: ACS Medicinal Chemistry Letters Vol. 6 Journal Issue: 12; ISSN 1948-5875
- Publisher:
- American Chemical SocietyCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Cited by: 29 works
Citation information provided by
Web of Science
Web of Science
Similar Records
Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii
Discovery of Clinical Candidate 1-{[(2 S ,3 S ,4 S )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives
Journal Article
·
Tue Jul 23 00:00:00 EDT 2013
· ACS Med.Chem.Lett 1:331,2010
·
OSTI ID:1227228
+10 more
Discovery of Clinical Candidate 1-{[(2 S ,3 S ,4 S )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
Journal Article
·
Mon Mar 27 00:00:00 EDT 2017
· Journal of Medicinal Chemistry
·
OSTI ID:1227228
+46 more
Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives
Journal Article
·
Thu Dec 11 00:00:00 EST 2014
· J. Med. Chem.
·
OSTI ID:1227228
+3 more